Acknowledgements

Authors

Yang Cao - "Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial" - ChiCTR-OPN-2000029580

Chen Jun - "Preliminary study of hydroxychloroquine sulfate in treating common coronavirus disease (COVID-19) patients in 2019" - NCT04261517

Ivan Fan-Ngai Hung - "Triple combination of interferon beta-1b, lopinavir?ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial" - NCT04276688

Yueping Li - "Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial" - NCT04252885

Wei Tang - "Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial" - ChiCTR2000029868

Yeming Wang - "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial" - NCT04257656

Fang Zheng - "A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19" - ChiCTR2000029496

Caleb P. Skipper - "Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19" - NCT04308668

Yao-Kai Chen - "Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia" - ChiCTR

Maria Isabel F Lopes - "Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial" - RBR-8jyhxh

George Sakoulas - "Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection" - NCT04411667

Sultan Mehmood Kamran - "Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (COVID-19)" - NCT04491994

Corral L - "USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION (GLUCOCOVID). Pragmatic trial inserted in real practice during a pandemic COVID-19" - EudraCT2020-001934-37

Yueping Li - "The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection (ELACOI)" - NCT04252885

Shu-Hsing Cheng - "Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19" - NCT04384380

Ling Li - "Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial" - ChiCTR2000029757

Editorial Team

Stephanie Weibel - Content Editor, Cochrane Emergency and Critical Care

Nathan Pace - Statistical Editor, Cochrane Emergency and Critical Care

Marialena Trivella - Statistical Editor, Cochrane Emergency and Critical Care

Janne Vendt - Information Specialist, Cochrane Emergency and Critical Care

Teo Quay - Managing Editor, Cochrane Emergency and Critical Care

Harald Herkner - Co-ordinating Editor, Cochrane Emergency and Critical Care